What do technology, AI and the Arts have in common? In part 2 of an interview with Susan Magsamen, founder and director of the International

Art for Art's sake is about to become passe with the emerging science of neuroaesthetics, an expanding field of research aimed at the intersection of

Alzheimer’s disease spares no one… and this story could easily be anyone’s story. Debra Tann Ed D., author of The Race of Dementia talks with

The Alzheimer’s journey tests and complicates the interpersonal dynamics in families as they try to protect the dignity and privacy of their loved ones. When

Should Alzheimer’s drugs be treated like all other drugs when it comes to Medicare coverage? The Alliance for Aging Research CEO Sue Peschin and BrainStorm

Alzheimer’s is being singled out in Medicare’s decision on reimbursement for patients. President of Global Alzheimer’s Platform Foundation and Co-Founder of UsAgainstAlzheimer’s, John Dwyer spoke

We the Scientists: How a Daring Team of Parents and Doctors Forged a New Path for Medicine

In Part 2 of the interview with

We the Scientists: How a Daring Team of Parents and Doctors Forged A New Path for Medicine

Pulitzer Prize winning Wall Street Reporter Amy Marcus, in

Want to improve your brain’s performance? Find out the latest from Dr. Sandra Bond Chapman, Founder and Chief Director of The Center for BrainHealth at